Parkman Healthcare Partners LLC raised its position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 36.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 294,788 shares of the biopharmaceutical company’s stock after acquiring an additional 78,144 shares during […]
Sectoral Asset Management Inc. cut its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 92.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,955 shares of the company’s stock after selling 167,240 shares during the quarter. Sectoral […]
Sectoral Asset Management Inc. cut its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 92.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,955 shares of the company’s stock after selling 167,240 shares during the quarter. Sectoral […]
Biogen Inc. (NASDAQ:BIIB – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 3,480,000 shares, a growth of 10.5% from the April 30th total of 3,150,000 shares. Based on an average daily volume of 1,220,000 shares, the […]
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price fell 5.5% during trading on Thursday . The company traded as low as $110.47 and last traded at $110.47. 17,348 shares changed hands during trading, a decline of 60% from the average session volume of 43,789 shares. The stock had previously closed at $116.84. Analyst […]